3.97
price down icon1.24%   -0.05
pre-market  Vorhandelsmarkt:  3.80   -0.17   -4.28%
loading

Finanzdaten der Lantern Pharma Inc-Aktie (LTRN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-07-01 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
4.3498
- 4.774 5.8964 5.1796
Operating Income/Loss
-4.3498
- -4.774 -5.8964 -5.1796
Income/Loss From Continuing Operations Before Tax
3.55%
-4.1774
-4.331 -4.5368 -5.8752 -4.5057
Income/Loss From Continuing Operations After Tax
3.55%
-4.1774
-4.331 -4.5368 -5.8752 -4.5057
Net Income/Loss
3.55%
-4.1774
-4.331 -4.5368 -5.8752 -4.5057
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10.83
- 10.78 0.0073 10.76
Diluted Average Shares
10.83
- 10.78 0.0073 10.76
Basic Earnings Per Share
-0.39
- -0.42 -0.54 -0.42
Diluted Earnings Per Share
-0.39
- -0.42 -0.54 -0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$97.55
price up icon 3.86%
$35.13
price up icon 0.29%
$57.77
price up icon 3.57%
ONC ONC
$297.65
price up icon 2.38%
$79.76
price up icon 10.01%
$189.24
price up icon 0.92%
Kapitalisierung:     |  Volumen (24h):